JPWO2021112055A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021112055A5 JPWO2021112055A5 JP2021562641A JP2021562641A JPWO2021112055A5 JP WO2021112055 A5 JPWO2021112055 A5 JP WO2021112055A5 JP 2021562641 A JP2021562641 A JP 2021562641A JP 2021562641 A JP2021562641 A JP 2021562641A JP WO2021112055 A5 JPWO2021112055 A5 JP WO2021112055A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- cell
- eso
- fragment
- cd1d
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019217704 | 2019-12-02 | ||
| JP2019217704 | 2019-12-02 | ||
| PCT/JP2020/044586 WO2021112055A1 (ja) | 2019-12-02 | 2020-12-01 | がんの処置に用いるｎｙ－ｅｓｏ－１含有人工アジュバントベクター細胞 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021112055A1 JPWO2021112055A1 (https=) | 2021-06-10 |
| JPWO2021112055A5 true JPWO2021112055A5 (https=) | 2023-10-30 |
| JP7646213B2 JP7646213B2 (ja) | 2025-03-17 |
Family
ID=76222293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562641A Active JP7646213B2 (ja) | 2019-12-02 | 2020-12-01 | がんの処置に用いるｎｙ－ｅｓｏ－１含有人工アジュバントベクター細胞 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US11672851B2 (https=) |
| EP (1) | EP4071240A4 (https=) |
| JP (1) | JP7646213B2 (https=) |
| KR (1) | KR20220119030A (https=) |
| CN (1) | CN114787344A (https=) |
| AR (1) | AR120648A1 (https=) |
| AU (1) | AU2020394993A1 (https=) |
| BR (1) | BR112022010763A2 (https=) |
| CA (1) | CA3162277A1 (https=) |
| CL (1) | CL2022001459A1 (https=) |
| CO (1) | CO2022008738A2 (https=) |
| CR (1) | CR20220320A (https=) |
| DO (1) | DOP2022000108A (https=) |
| EC (1) | ECSP22049399A (https=) |
| IL (1) | IL293482A (https=) |
| JO (1) | JOP20220121A1 (https=) |
| MX (1) | MX2022006716A (https=) |
| PE (1) | PE20221463A1 (https=) |
| PH (1) | PH12022551334A1 (https=) |
| TW (1) | TW202134431A (https=) |
| WO (1) | WO2021112055A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130189302A1 (en) * | 2006-02-22 | 2013-07-25 | Riken | Immunotherapeutic method using artificial adjuvant vector cells that co-express cd1d and target antigen |
| WO2025230010A1 (ja) * | 2024-05-02 | 2025-11-06 | 国立研究開発法人理化学研究所 | ＣＤ１ｄ導入前にＣＤ１ｄリガンドでインキュベートされた細胞 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5672647B2 (ja) * | 2006-02-22 | 2015-02-18 | 独立行政法人理化学研究所 | ＣＤ１ｄリガンドをパルスした、標的抗原及びＣＤ１ｄの共発現細胞による免疫療法 |
| US20130189302A1 (en) * | 2006-02-22 | 2013-07-25 | Riken | Immunotherapeutic method using artificial adjuvant vector cells that co-express cd1d and target antigen |
| JP2007261876A (ja) | 2006-03-28 | 2007-10-11 | Tdk Corp | 誘電体粒子、誘電体磁器組成物およびその製造方法 |
| WO2008057795A2 (en) * | 2006-10-27 | 2008-05-15 | Temple University - Of The Commonwealth System Of Higher Education | Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera |
| AU2008219020B2 (en) * | 2007-02-21 | 2013-08-22 | Vaccinex, Inc. | Modulation of NKT cell activity with antigen-loaded CDId molecules |
| JPWO2010061930A1 (ja) * | 2008-11-28 | 2012-04-26 | 独立行政法人理化学研究所 | ＣＤ１ｄ及び標的抗原の共発現アロ細胞を用いた免疫療法 |
| KR101194265B1 (ko) | 2008-12-01 | 2012-10-29 | 주식회사 한국인삼공사 | 해양심층수를 이용하여 인삼 또는 홍삼 농축액의 고미 제거방법 |
| BR112012024375A2 (pt) | 2010-03-25 | 2016-05-24 | 3M Innovative Properties Co | camada compósita |
| EP2738253A4 (en) | 2011-07-29 | 2015-04-22 | Riken | CELL FOR USE IN IMMUNOTHERAPY WITH A MODIFIED NUCLEIC ACIDIC CONSTRUCTIVE FOR WILMS TUMORGEN PRODUCT OR FRAGMENT THEREOF, METHOD FOR PRODUCING THIS CELL AND NUCLEIC ACIDIC CONCRETE SAID |
| US10316332B2 (en) * | 2011-07-29 | 2019-06-11 | Riken | Cell for immunotherapy, including modified nucleic acid construct encoding Wilms tumor gene product |
| CN108064176A (zh) * | 2015-04-22 | 2018-05-22 | 库瑞瓦格股份公司 | 用于治疗肿瘤疾病的含有rna的组合物 |
| EP3328988A1 (en) | 2015-07-31 | 2018-06-06 | Synlogic, Inc. | Bacteria engineered to treat disorders involving propionate catabolism |
| US20170216370A1 (en) | 2015-07-31 | 2017-08-03 | Synlogic, Inc. | Bacteria engineered to treat disorders involving propionate catabolism |
| JP2020514370A (ja) * | 2017-03-17 | 2020-05-21 | キュアバック アーゲー | 組合せ抗癌療法のためのｒｎａワクチン及び免疫チェックポイント阻害剤 |
-
2020
- 2020-12-01 AU AU2020394993A patent/AU2020394993A1/en not_active Abandoned
- 2020-12-01 PH PH1/2022/551334A patent/PH12022551334A1/en unknown
- 2020-12-01 US US17/781,616 patent/US11672851B2/en active Active
- 2020-12-01 CA CA3162277A patent/CA3162277A1/en active Pending
- 2020-12-01 AR ARP200103335A patent/AR120648A1/es unknown
- 2020-12-01 PE PE2022000986A patent/PE20221463A1/es unknown
- 2020-12-01 BR BR112022010763A patent/BR112022010763A2/pt not_active IP Right Cessation
- 2020-12-01 CR CR20220320A patent/CR20220320A/es unknown
- 2020-12-01 EP EP20895978.3A patent/EP4071240A4/en active Pending
- 2020-12-01 IL IL293482A patent/IL293482A/en unknown
- 2020-12-01 KR KR1020227020633A patent/KR20220119030A/ko not_active Ceased
- 2020-12-01 JP JP2021562641A patent/JP7646213B2/ja active Active
- 2020-12-01 MX MX2022006716A patent/MX2022006716A/es unknown
- 2020-12-01 WO PCT/JP2020/044586 patent/WO2021112055A1/ja not_active Ceased
- 2020-12-01 CN CN202080084442.2A patent/CN114787344A/zh active Pending
- 2020-12-01 TW TW109142233A patent/TW202134431A/zh unknown
-
2022
- 2022-05-23 JO JOP/2022/0121A patent/JOP20220121A1/ar unknown
- 2022-05-24 DO DO2022000108A patent/DOP2022000108A/es unknown
- 2022-06-02 CL CL2022001459A patent/CL2022001459A1/es unknown
- 2022-06-23 CO CONC2022/0008738A patent/CO2022008738A2/es unknown
- 2022-06-24 EC ECSENADI202249399A patent/ECSP22049399A/es unknown
-
2023
- 2023-05-15 US US18/317,358 patent/US20230330200A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Huber et al. | The immune microenvironment in pancreatic cancer | |
| Bienkowska et al. | Cancer-associated fibroblasts in oral cancer: a current perspective on function and potential for therapeutic targeting | |
| Nair et al. | Natural killer T cells in cancer immunotherapy | |
| Aponte et al. | Stemness in cancer: stem cells, cancer stem cells, and their microenvironment | |
| JPWO2021112055A5 (https=) | ||
| Rajasekar et al. | Epigenetic changes in endothelial progenitors as a possible cellular basis for glycemic memory in diabetic vascular complications | |
| Guan et al. | Sorafenib enriches epithelial cell adhesion molecule–positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2‐AKT cascade | |
| Raffaghello et al. | Classification and biology of tumour associated stromal cells | |
| Rousseau et al. | Lipopolysaccharide-induced toll-like receptor 4 signaling enhances the migratory ability of human esophageal cancer cells in a selectin-dependent manner | |
| JP2010514455A5 (https=) | ||
| FI3294325T3 (fi) | Car-muokattujen t-solujen vaikutuksen parantaminen nukleeinihapporokotuksella | |
| Wang et al. | Breast cancer stem cells: signaling pathways, cellular interactions, and therapeutic implications | |
| Takami et al. | Clinical application of iNKT cell-mediated anti-tumor activity against lung cancer and head and neck cancer | |
| Wu et al. | Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma | |
| Chan et al. | Turning hepatic cancer stem cells inside out–a deeper understanding through multiple perspectives | |
| PL2102331T3 (pl) | Szczepionka przeciwnowotworowa otrzymana z prawidłowych, chemicznie modyfikowanych komórek CD4+ | |
| Wen et al. | Role and mechanism of programmed death-ligand 1 in hypoxia-induced liver cancer immune escape | |
| AR086306A1 (es) | Anticuerpos para el tratamiento del cancer | |
| WO2015095354A3 (en) | Compositions and methods for treating fatty tissue buildup | |
| JP2016510594A5 (https=) | ||
| Dashtsoodol et al. | Natural killer T cell-targeted immunotherapy mediating long-term memory responses and strong antitumor activity | |
| Jumaniyazova et al. | The role of macrophages in various types of tumors and the possibility of their use as targets for antitumor therapy | |
| Morini et al. | Exosomes and immune modulation: implications for neuroblastoma immunotherapy | |
| Huart et al. | Could protons and carbon ions be the silver bullets against pancreatic cancer? | |
| Yang et al. | Unleashing the therapeutic potential of tumor-draining lymph nodes: spotlight on bladder cancer |